•
•
•
•
For Immediate Release
Friday, April 18, 2008
Contact:
Marsha Love
Joyce Rudick
(301) 402-1770
lovem@orwh.od.nih.gov
rudickj@orwh.od.nih.gov
Three New Members Named to NIH Advisory Committee on Research on Women’s Health
Three new members have been appointed to the National Institutes of Health (NIH) Advisory Committee on Research on Women’s Health (ACRWH), which held its semiannual meeting on March 17 in Bethesda, Maryland. The new members are: Linda C. Giudice, M.D., Ph.D., who is the Robert B. Jaffe, M.D., Endowed Professor and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco; Nancy H. Nielsen, M.D., Ph.D., who is the Senior Associate Dean, State University of New York at Buffalo School of Medicine and Biomedical Sciences, and also the President-elect of the American Medical Association (AMA); and Debra Toney, Ph.D., R.N., who is the President of the National Black Nurses Association (NBNA) and the Administrator, Rainbow Medical Centers, Las Vegas, Nevada.
The NIH Revitalization Act of 1993 charges the Advisory Committee with advising the Director of the Office of Research on Women’s Health on appropriate research activities to be undertaken by the national research institutes with respect to women’s health research and recommendations regarding the inclusion of women in clinical trials and opportunities for women in biomedical careers. The committee is composed of up to 18 members who are appointed by the NIH Director.
Dr. Giudice is a biochemist, gynecologist, and reproductive endocrinologist whose research focuses on endometrial biology and placental-uterine interactions, as well as environmental impacts on reproductive health. She is recognized for her extensive knowledge on the topics of endometriosis, implantation and ovulatory disorders, infertility, and assisted reproduction. She recently chaired the NIH Reproductive Medicine Network and was on the Board of Directors of the American Society for Reproductive Medicine from 2002–2007. She currently sits on the Society for Women's Health Research Board of Directors and the Institute of Medicine Health Sciences Policy Board.
Long active in organized medicine, Dr. Nielsen, who has served as Speaker of the House of Delegates of the Medical Society of the State of New York and as Speaker of the AMA House of Delegates, was named president-elect of the AMA in June 2007. Following a year-long term as president-elect, Dr. Nielsen will assume the office of AMA president in June 2008. She will be the second woman to hold the AMA's highest elected office. Dr. Nielsen helped formulate policy positions for the AMA House of Delegates on such issues as depression, alcoholism among women, Alzheimer’s disease, and priorities in clinical preventive services. Dr. Nielsen is active at the national level in a variety of quality initiatives including the Institute of Medicine’s Roundtable on Evidence Based Medicine and the Consumer Empowerment Committee of America’s Health Information Community. A board certified internist, she has been named a Master of the American College of Physicians.
Elected the 10th President of the NBNA in November 2007, Dr. Toney will be installed as NBNA President on August 5, 2008. With over 28 years of experience in health care leadership roles in family practice management, ambulatory care, outpatient diagnostics, hospitals and home health care, she is currently responsible for the oversight of six primary/urgent care centers and an outpatient diagnostic center in Las Vegas, Nevada. Dr. Toney, a Robert Wood Johnson Executive Nurse Fellow, is the president/owner of TLC Healthcare Services, a licensed home healthcare agency specializing in private duty nursing and supportive care services. She developed the Men’s Health Network and is a board member of the Jourdain Kasey Foundation, which is dedicated to increasing awareness and early detection of ovarian cancer. The recipient of numerous awards, Dr. Toney frequently speaks on leadership, men and women’s health, and policy and practice issues at the national and local levels.
Continuing ACRWH members include:
Vivian W. Pinn, M.D., , Chairperson, Associate Director for Research on Women's Health, Director, Office of Research on Women's Health (ORWH), NIH, Bethesda, MD; Joyce Rudick, Executive Secretary, Director, Programs and Management, ORWH, NIH, Bethesda, MD; Alan M. Krensky, M.D., Ex-Officio, Director, Office of Portfolio Analysis and Strategic Initiatives, Office of the Director, NIH, Bethesda, MD; Luther Clark, M.D., Executive Director, Atherosclerosis, External Medical and Scientific Affairs, Cardiovascular/Metabolic Business Unit, Merck and Company, North Wales, PA; PonJola Coney, M.D., Senior Associate Dean for Faculty Affairs, Virginia Commonwealth University, Richmond, VA; Andrea Dunaif, M.D., Charles F. Kettering Professor of Medicine and Chief, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, Chicago, IL; Ronald S. Gibbs, M.D., Professor and Chairman, Department of Obstetrics and Gynecology, University of Colorado Healthsciences Center, Denver, CO; Constance A. Howes, J.D., President and CEO, Women and Infants Hospital, Providence RI; Scott J. Hultgren, Ph.D., Helen L. Stoever Professor of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO; Linda M. Kaste, D.D.S., Ph.D., Associate Professor and Director of Predoctoral Dental Public Health, University of Illinois at Chicago, Chicago, IL; Nancy Norton, Founder and President, International Foundation for Functional Gastrointestinal Disorders, Milwaukee, WI; Mary Beth O’Connell, Pharm.D., Associate Professor, Wayne State University, Detroit MI; Mary I. O’Connor, M.D., Chair, Department of Orthopedic Surgery, Department of Orthopedics, Mayo Clinic, Jacksonville, FL; Eugene P. Orringer, M.D., Executive Associate Dean for Faculty Affairs and Faculty Development, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; Sally Rosen, M.D., Special Assistant, Office of the Provost Director, Center for Women’s Health Research, Leadership and Advocacy, Office of the Vice President for Research, Temple University, Philadelphia, PA; Susan P. Sloan, M.D., Program Director, Internal Medicine, Drexel University’s College of Medicine, Easton, PA; Barbara Yee, Ph.D., Professor and Chair, Department of Family and Consumer Sciences, University of Hawaii at Manoa, Honolulu, HI; and Carmen D. Zorrilla, M.D., Professor OB-GYN, University of Puerto Rico School of Medicine, San Juan, PR.
The Office of Research on Women's Health (ORWH), Office of the Director, National Institutes of Health (NIH) serves as a focal point for women's health research at the NIH. For more information about NIH's Office of Research on Women's Health, visit http://orwh.od.nih.gov/ and for additional information on the ACRWH, go to http://orwh.od.nih.gov/about/advisory.html.
The Office of the Director, the central office at NIH, is responsible for setting policy for NIH, which includes 27 Institutes and Centers. This involves planning, managing, and coordinating the programs and activities of all NIH components. The Office of the Director also includes program offices which are responsible for stimulating specific areas of research throughout NIH. Additional information is available at http://www.nih.gov/icd/od/.
The National Institutes of Health – the Nation’s Medical Research Agency—is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH Newsworthy Notes on Women's Health (September, 2007)
Newsworthy Notes Archives
The NIH Reauthorization Act of 1993 provides the organizational structure of the ACRWH:
(1) In carrying out subsection (b), the Director of the Office shall establish an advisory committee to be known as the Advisory Committee on Research on Women's Health (in this subsection referred to as the Advisory Committee').
(2) The Advisory Committee shall be composed of no fewer than 12, and not more than 18 individuals, who are not officers or employees of the Federal Government. The Director of the Office shall make appointments to the Advisory Committee from among physicians, practitioners, scientists, and other health professionals, whose clinical practice, research specialization, or professional expertise includes a significant focus on research on women's health. A majority of the members of the Advisory Committee shall be women.
(3) The Director of the Office shall serve as the chair of the Advisory Committee.
(4) The Advisory Committee shall--
(A) advise the Director of the Office on appropriate research activities to be undertaken by the national research institutes with respect to--
(i) research on women's health;
(ii) research on gender differences in clinical drug trials, including responses to pharmacological drugs;
(iii) research on gender differences in disease etiology, course, and treatment;
(iv) research on obstetrical and gynecological health conditions, diseases, and treatments; and
(v) research on women's health conditions which require a multidisciplinary approach;
(B) report to the Director of the Office on such research;
(C) provide recommendations to such Director regarding activities of the Office (including recommendations on the development of the methodologies described in subsection (c)(4)(C) and recommendations on priorities in carrying out research described in subparagraph (A)); and
(D) assist in monitoring compliance with section 492B regarding the inclusion of women in clinical research.
(5)
(A) The Advisory Committee shall prepare a biennial report describing the activities of the Committee, including findings made by the Committee regarding--
(i) compliance with section 492B;
(ii) the extent of expenditures made for research on women's health by the agencies of the National Institutes of Health; and
(iii) the level of funding needed for such research.
(B) The report required in subparagraph (A) shall be submitted to the Director of NIH for inclusion in the report required in section 403.
Members of the Advisory Committee on Research on Women's Health (ACRWH) provided leadership in developing An Agenda for Research on Women's Health for the 21st Century, NIH's blueprint for women's health research in the new Millennium, the biennial report, Report of the Advisory Committee on Research on Women's Health: Office of Research on Women's Health and NIH Support for Research on Women's Health Issues describing NIH research and other efforts related to women's health, and are actively involved in reviewing research priorities, the women's health research portfolio for NIH, career development programs, conferences, and outreach activities. The ACRWH is composed of up to 18 members, chosen from among physicians, practitioners, scientists, and other health professionals, whose clinical practice, research specialization, or professional expertise includes a significant focus on research on women's health. The Committee is authorized to:
Overview
Membership Roster
NIH Newsworthy Notes on Women's Health
March, 2007
